Central nervous system disease in phase III studies for advanced HER2 positive breast cancer: A review

IMPORTANCE: The introduction of human epidermal growth factor receptor 2 (HER2) directed therapy has transformed the outcomes of patients with advanced breast cancer (BC). However, HER2 positive breast cancer has a predilection for the central nervous system (CNS) which is associated with significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhogal, Talvinder, Cameron, David, Palmieri, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961215/
https://www.ncbi.nlm.nih.gov/pubmed/35344688
http://dx.doi.org/10.1016/j.breast.2022.03.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961215/
https://www.ncbi.nlm.nih.gov/pubmed/35344688
http://dx.doi.org/10.1016/j.breast.2022.03.013

Ejemplares similares